Yearly Archives: 2024

/2024

Medicine Supply Notification: Naloxone (Nyxoid® ) 1.8mg/0.1ml nasal spray unit dose

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose MSN/2024/093 Tier 2 – medium impact Date of issue: 28th August 2024 Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose is out of stock until w/c 30th September 2024. Naloxone 1.26mg/0.1ml nasal spray unit dose [...]

The post Medicine Supply Notification: Naloxone (Nyxoid® ) 1.8mg/0.1ml nasal spray unit dose appeared first on Community Pharmacy England.

By |August 28th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Naloxone (Nyxoid® ) 1.8mg/0.1ml nasal spray unit dose

Drug Tariff Watch – September 2024

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – September 2024 appeared first on Community Pharmacy England.

By |August 28th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – September 2024

MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd)

Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Drug alert number: EL (24)A/340 Date issued: 27 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Company name: Chemidex Pharma Ltd [...]

The post MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) appeared first on Community Pharmacy England.

By |August 27th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd)

Medicine Supply Notification: Isosorbide mononitrate 60mg modified-release tablets and capsules updated

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate 60mg modified-release tablets and capsules. MSN/2024/092 Tier 2 – medium impact Date of issue: 17th September 2024 Chemydur® 60XL tablets are out of stock until late September 2024. Monomax® XL 60mg tablets are out of stock until early October [...]

The post Medicine Supply Notification: Isosorbide mononitrate 60mg modified-release tablets and capsules updated appeared first on Community Pharmacy England.

By |August 27th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Isosorbide mononitrate 60mg modified-release tablets and capsules updated

Nearly a sixth of pharmacies could close within a year, Pressures Survey indicates

Community Pharmacy England has today released a national report confirming the severe financial pressures putting community pharmacies at risk of closure, threatening patient care and access to services across England. The Pharmacy Pressures Survey 2024: Funding and Profitability Report sets out what pharmacy owners and their teams have told us about the depths of the [...]

The post Nearly a sixth of pharmacies could close within a year, Pressures Survey indicates appeared first on Community Pharmacy England.

By |August 25th, 2024|Lexpos News|Comments Off on Nearly a sixth of pharmacies could close within a year, Pressures Survey indicates